Molecular immunology
You have full text access to this OnlineOpen article
SWAP-70 regulates mast cell FcϵRI-mediated signaling and anaphylaxis
Article first published online: 30 JAN 2008
DOI: 10.1002/eji.200737597
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Sivalenka, Raja R., Sinha, M. and Jessberger, R. (2008), SWAP-70 regulates mast cell FcϵRI-mediated signaling and anaphylaxis. Eur. J. Immunol., 38: 841–854. doi: 10.1002/eji.200737597
Publication History
- Issue published online: 19 FEB 2008
- Article first published online: 30 JAN 2008
- Manuscript Accepted: 12 DEC 2007
- Manuscript Revised: 7 NOV 2007
- Manuscript Received: 26 JUN 2007
Funded by
- NIH (AI 049282)
- 1and A B-cell-specific DNA recombination complex. J. Biol. Chem. 1998 273: 17025–17035.
- 2and SWAP-70-deficient mast cells are impaired in development and IgE-mediated degranulation. Eur. J. Immunol. 2002 32: 1121–1128.
- 3Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 2001 26: 724–732.
- 4and GEF means go: Turning on Rho GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 2005 6: 167–180.
- 5and Small GTP-binding proteins. Physiol. Rev. 2001 81: 153–208.
- 6and Rho GTPases in cell biology. Nature 2002 420: 629–635.
- 7SWAP-70 is a guanine-nucleotide-exchange factor that mediates signalling of membrane ruffling. Nature 2002 416: 759–763.
- 8and Impaired IgE response in SWAP-70-deficient mice. Eur. J. Immunol. 2001 31: 2467–2475.
- 9and Association of SWAP-70 with the B cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 2000 97: 2180–2184.
- 10and Pleckstrin homology domains and the cytoskeleton. FEBS Lett. 2002 513: 71–76.
- 11and Activity of beta3-beta4 loop of the PH domain is required for the membrane targeting of SWAP-70. IUBMB Life 2007 59: 99–103.Direct Link:
- 12and Localized Rac activation dynamics visualized in living cells. Science 2000 290: 333–337.
- 13and Def-2, -3, -6 and -8, novel mouse genes differentially expressed in the haemopoietic system. Br. J. Haematol. 1999 106: 335–344.
- 14SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 2003 18: 403–414.
- 15and Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum. Immunol. 2003 64: 389–401.
- 16and SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration. Mol. Cell. Biol. 2004 24: 10277–10288.
- 17
- 18and Mast-cell growth and differentiation. Allergy 1999 54: 306–312.
- 19and Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005 6: 135–142.
- 20and Mast cells – key effector cells in immune responses. Trends Immunol. 2007 28: 234–241.
- 21and Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001 14: 801–811.
- 22Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl. Acad. Sci. USA 2003 100: 12911–12916.
- 23IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 2005 105: 3222–3229.
- 24Fc receptor biology. Annu. Rev. Immunol. 1997 15: 203–234.
- 25and Fc(epsilon)RI-dependent signaling pathways in human mast cells. Clin. Immunol. 2001 99: 198–210.
- 26and A perspective: Regulation of IgE receptor-mediated mast cell responses by a LAT-organized plasma membrane-localized signaling complex. Int. Arch. Allergy Immunol. 2001 124: 137–141.
- 27and Roles of adaptor molecules in mast cell activation. Chem. Immunol. Allergy 2005 87: 43–58.
- 28and Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006 6: 218–230.
- 29and Intracellular signaling pathways in IgE-dependent mast cell activation. Arch. Immunol. Ther. Exp. (Warsz.) 2006 54: 393–401.
- 30and Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 1991 174: 7–14.
- 31and Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur. J. Immunol. 1994 24: 822–826.
- 32and Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Int. Arch. Allergy Appl. Immunol. 1986 80: 285–290.
- 33and Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 1993 75: 969–976.
- 34and Conjugated avidin binds to mast cell granules. J. Histochem. Cytochem. 1985 33: 27–32.
- 35and Mutational analysis on the function of the SWAP-70 PH domain. Mol. Cell. Biochem. 2006 293: 137–145.
- 36Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992 176: 1381–1386.
- 37and In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation. J. Allergy Clin. Immunol. 2000 105: 134–142.
- 38and Anchorage-dependent ERK signaling – mechanisms and consequences. Curr. Opin. Genet. Dev. 2002 12: 30–35.
- 39and Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298: 1911–1912.
- 40and The quantity and duration of FcRgamma signals determine mast cell degranulation and survival. Blood 2004 103: 3093–3101.
- 41and Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 1999 162: 2087–2094.
- 42and Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells. Mol. Cell. Biol. 2001 21: 3763–3774.
- 43and ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J. Biol. Chem. 2000 275: 15799–15808.
- 44and Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: Involvement of p38 MAPK. J. Leukoc. Biol. 2004 76: 1075–1081.
- 45and IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood 2003 102: 1405–1413.
- 46and Role of phosphoinositide 3-kinase signaling in mast cells: New insights from knockout mouse studies. J. Mol. Med. 2003 81: 524–535.
- 47The phosphoinositide 3-kinase pathway. Science 2002 296: 1655–1657.
- 48and Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J. Biol. Chem. 1997 272: 7927–7931.
- 49and Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol. Rev. 2000 176: 19–29.Direct Link:
- 50and Regulation of phospholipase C gamma isoforms in haematopoietic cells: Why one, not the other? Cell Signal. 2001 13: 691–701.
- 51and The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J. Biol. Chem. 2003 278: 48474–48484.
- 52and Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 1993 268: 1749–1756.
- 53and LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000 12: 525–535.
- 54and Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 1989 83: 1375–1383.
- 55and The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J. Exp. Med. 2003 198: 831–843.
- 56and SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J. Clin. Invest. 1999 103: 1737–1743.
- 57Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 1998 187: 1235–1247.
- 58Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I alpha. J. Exp. Med. 2005 201: 859–870.
- 59and c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J. Immunol. 2004 173: 2571–2577.
- 60and Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 2005 174: 1063–1072.
- 61IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism. J. Immunol. 1998 161: 6915–6923.
- 62Interleukin-6 and mast cells. Allergy Asthma Proc. 2002 23: 331–335.
- 63and Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells. Mol. Immunol. 2007 44: 3416–3426.
- 64and IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells. J. Immunol. 2005 175: 5430–5438.
- 65and Distinct Ras effector pathways are involved in Fc epsilon R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J. Exp. Med. 1997 185: 43–53.
- 66and Akt-dependent cytokine production in mast cells. J. Exp. Med. 2000 192: 729–740.
- 67and PKB binding proteins. Getting in on the Akt. Cell 2002 111: 293–303.
- 68Rac2 stimulates Akt activation affecting BAD/Bcl-xl expression while mediating survival and actin function in primary mast cells. Immunity 2000 12: 557–568.
- 69and Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in Fc epsilon RI signaling in RBL 2H3 mast cells. J. Immunol. 2001 166: 1627–1634.
- 70and A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature 2006 444: 230–234.
- 71Essential role for Gab2 in the allergic response. Nature 2001 412: 186–190.
- 72Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004 431: 1007–1011.
- 73Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 2003 197: 1453–1465.

1521-4141/asset/2040_left.gif?v=1&s=92837c2f17424f89abf3f45e2642c107d62e6c04)
1521-4141/asset/EJI_right.gif?v=1&s=bce6d64154702bbe279104b1163baee31019fb77)
